Highlights Sona Nanotech Inc.

Equities

SONA

CA83541C1059

Market Closed - Canadian Securities Exchange Other stock markets 03:59:59 2024-04-30 pm EDT			5-day change	1st Jan Change
0.36 ^CAD	+2.86%		-14.29%	+50.00%

Apr. 12	Sona Nanotech Provides Interim Results of Dalhousie Study	MT
Apr. 12	Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sona Nanotech Provides Interim Results of Dalhousie Study	Apr. 12	MT
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	Apr. 12	CI
Sona Nanotech Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 29	CI
Sona Nanotech Inc. Announces Filing of Provisional Patent Application	Mar. 18	CI
Sona Nanotech Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Feb. 27	CI
Sona Nanotech Inc. Provides Corporate Update on Operating Activities	23-10-12	CI
Sona Nanotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-28	CI
Sona Nanotech Inc. Announces Innovative Research Initiative to Undertake with Giacomantonio Immuno-Oncology Research Group	23-09-11	CI
Sona Nanotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28	CI
Sona Nanotech Inc. Announces First Territorial Patent Grant for Its Proprietary, Toxin-Free Gold Nanorod Manufacturing Process with A Registration in South Korea	23-05-18	CI
Sona Nanotech Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-30	CI
Sona Nanotech Inc. completed the acquisition of Siva Therapeutics Inc.	23-03-22	CI
Sona Nanotech Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-02-26	CI
Sona Nanotech Inc. completed the acquisition of Siva Therapeutics, Inc.	23-02-26	CI
Sona Nanotech Inc. Receives Technology Assessment Results from NCL	23-02-08	CI
Sona Nanotech Inc. entered into a binding agreement to acquire Siva Therapeutics Inc. for $8.7 million.	23-01-25	CI
Sona Nanotech Inc. Enters Memorandum of Understanding with Biotangents Limited	22-11-08	CI
Sona Nanotech Inc. Enters into Agreement to Supply Certain Gold Nanorod Material to Siva Therapeutics, Inc	22-10-20	CI
Sona Nanotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-26	CI
Sona Nanotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sona Nanotech Inc.

Equities

SONA

CA83541C1059

Highlights

Filters